CSG Systems International, Inc. - CSGS

CSGS Returns vs S&P 500 ⓘ

ticker	1 day return %	1 week return %	1 month return %	3 months return %	6 months return %	1 year return %	3 years return %	5 years return %	10 years return %	maximum return %
CSGS	-0.6	20.1	16.6	18.6	32.2	11.5	3.7	-0.8	115.8	383.3
S&P 500	0.4	4.7	3.7	12.2	14.8	35.8	29.0	94.2	194.1	33849.8

Compare CSGS with other assets →

Returns Charts ⓘ

Interactive Price Chart

Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline

Real-time Full Quote

Attribute	Value
symbol	CSGS
name	CSG Systems International, Inc.
price	55.58
changes percentage	-0.63
change	-0.35
day low	54.57
day high	56.28
year high	57.16
year low	39.56
market cap	1639634783
price avg 50	47.93
price avg 200	47.03
exchange	NASDAQ
volume	349739
avg volume	212140
open	55.57
previous close	55.93
eps	2.43
pe	22.87
earnings announcement	2024-11-06T05:00:00.000+0000
shares outstanding	29503100
timestamp	2024-11-08 21:00:01

Financial Statements ⓘ

We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.

Overall Annual Financial Health: 68.0%

Overall Quarterly Financial Health: 64.3%

Income Statements ⓘ

• Annual Income Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0001005757
revenue	1169258000	1089752000	7.30
gross profit	527294000	524584000	0.52
gross profit ratio	0.45	0.48	-6.32
research and development expenses	143201000	137913000	3.83
operating expenses	383232000	399529000	-4.08
interest income	4336000	877000	394.41
interest expense	31176000	16432000	89.73
ebitda	213351000	207928000	2.61
ebitdaratio	0.18	0.19	-4.37
operating income	144062000	130977000	9.99
operating income ratio	0.12	0.12	2.51
net income	66246000	44060000	50.35
net income ratio	0.06	0.04	40.13
eps	2.21	1.42	55.63

Overall Score of Annual Income Statement

1.0 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 1,169 million in 2023 from 1,090 million in 2022 representing a change of 7.3%. This indicates a sales growth, which is a positive sign for the company.

  Gross Profit: Gross Profit increased to 527 million in 2023 from 525 million in 2022 representing a change of 0.52%. This indicates a sales profitability growth, which is a positive sign for the company.

  Research and Development (R&D) Expenses: R&D Expenses increased to 143 million in 2023 from 138 million in 2022 representing a change of 3.83%. This shows that the company continues to invest in innovation and product development, which is crucial for long-term growth.

  Operating Expenses: Operating Expenses decreased to 383 million in 2023 from 400 million in 2022 representing a change of -4.08%. The decrease in operating expenses can be attributed to various factors such as improved profitability, cost optimization and financial stability, lower operating expenses can be positive indicators.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to 213 million in 2023 from 208 million in 2022 representing a change of 2.61%. The increase in EBITDA indicates improved operational efficiency and profitability.

  Operating Income: Operating income increased to 144 million in 2023 from 131 million in 2022 representing a change of 9.99%. The increase in operating income indicates better operational performance and increased profitability.

  Net Income: Net income increased to 66 million in 2023 from 44 million in 2022 representing a change of 50.35%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 2.21 in 2023 from 2.21 in 2022 representing a change of 55.63%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.

• Quarterly Income Statement

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0001005757
revenue	295143000	290318000	1.66
gross profit	145656000	132089000	10.27
gross profit ratio	0.49	0.45	8.47
research and development expenses	41665000	38411000	8.47
operating expenses	113834000	98534000	15.53
interest income	1922000	2103000	-8.61
interest expense	-7778000	7698000	-201.04
ebitda	31822000	50892000	-37.47
ebitdaratio	0.11	0.18	-38.49
operating income	31822000	33555000	-5.16
operating income ratio	0.11	0.12	-6.72
net income	19088000	13829000	38.03
net income ratio	0.06	0.05	35.77
eps	0.67	0.48	39.58

Overall Score of Quarterly Income Statement

0.75 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 295 million in 2024Q3 from 290 million in 2024Q2 representing a change of 1.66%. This indicates a sales growth, which is a positive sign for the company.

  Gross Profit: Gross Profit increased to 146 million in 2024Q3 from 132 million in 2024Q2 representing a change of 10.27%. This indicates a sales profitability growth, which is a positive sign for the company.

  Research and Development (R&D) Expenses: R&D Expenses increased to 42 million in 2024Q3 from 38 million in 2024Q2 representing a change of 8.47%. This shows that the company continues to invest in innovation and product development, which is crucial for long-term growth.

  Operating Expenses: Operating Expenses decreased to 114 million in 2024Q3 from 99 million in 2024Q2 representing a change of 15.53%. The decrease in operating expenses can be attributed to various factors such as improved profitability, cost optimization and financial stability, lower operating expenses can be positive indicators.

  Net Income: Net income increased to 19 million in 2024Q3 from 14 million in 2024Q2 representing a change of 38.03%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 0.67 in 2024Q3 from 0.67 in 2024Q2 representing a change of 39.58%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.

• 📉 Negative Indicators

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) decreased to 32 million in 2024Q3 from 51 million in 2024Q2 representing a change of -37.47%. The decrease in EBITDA indicates declined operational efficiency and profitability.

  Operating Income: Operating income decreased to 32 million in 2024Q3 from 34 million in 2024Q2 representing a change of -5.16%. The decrease in operating income indicates worse operational performance and decreased profitability.

Balance Sheets ⓘ

• Annual Balance Sheet

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0001005757
total assets	1443046000	1348553000	7.01
total liabilities	1169720000	993304000	17.76
total equity	273326000	355249000	-23.06
cash and cash equivalents	186264000	150365000	23.87
short term investments	186264000	71000	262,243.66
long term investments	54421000	150365000	-63.81
total current assets	862226000	765955000	12.57
total non current assets	580820000	582598000	-0.31
total current liabilities	560836000	527209000	6.38
total non current liabilities	608884000	466095000	30.64
common stock	713000	708000	0.71
retained earnings	968134000	936215000	3.41
total debt	592803000	487188000	21.68

Overall Score of Annual Balance Sheet

0.6 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 1,443 million in 2023 from 1,349 million in 2022 representing a change of 7.01%. Suggesting a growth in asset holdings.

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 186 million in 2023 from 150 million in 2022 representing a change of 23.87%. This indicates an increase in available liquid assets.

  Short Term Investments: Short Term Investments increased to 186 million in 2023 from 0 million in 2022 representing a change of 262243.66%. This indicates an increase in short-term investment holdings.

  Total Current Assets: Total Current Assets increased to 862 million in 2023 from 766 million in 2022 representing a change of 12.57%. This indicates a better liquidity position.

  Common Stock: Common Stock increased to 1 in 2023 from 1 in 2022 representing a change of 0.71%. This indicates an increase in ownership interest.

  Retained Earnings: Retained Earnings increased to 968 million in 2023 from 936 million in 2022 representing a change of 3.41%. This indicates an accumulated profits.

• 📉 Negative Indicators

  Total Liabilities: Total Liabilities increased to 1,170 million in 2023 from 993 million in 2022 representing a change of 17.76%. This indicates an increase in overall liabilities.

  Total Equity: Total Equity decreased to 273 million in 2023 from 355 million in 2022 representing a change of -23.06%. This indicates a decrease in shareholders' equity.

  Total Current Liabilities: Total Current Liabilities increased to 561 million in 2023 from 527 million in 2022 representing a change of 6.38%. This indicates a higher short-term debt burden.

  Total Debt: Total Debt increased to 593 million in 2023 from 487 million in 2022 representing a change of 21.68%. This indicates an increase in overall debt burden.

• Quarterly Balance Sheet

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0001005757
total assets	1387446000	1353288000	2.52
total liabilities	1099035000	1079959000	1.77
total equity	288411000	273329000	5.52
cash and cash equivalents	118444000	110435000	7.25
short term investments	0	0	NaN
long term investments	0	125354000	-100.00
total current assets	787240000	759041000	3.72
total non current assets	600206000	594247000	1.00
total current liabilities	499509000	476444000	4.84
total non current liabilities	599526000	603515000	-0.66
common stock	717000	717000	0.00
retained earnings	0	983788000	-100.00
total debt	577915000	583045000	-0.88

Overall Score of Quarterly Balance Sheet

0.62 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 1,387 million in 2024Q3 from 1,353 million in 2024Q2 representing a change of 2.52%. Suggesting a growth in asset holdings.

  Total Equity: Total Equity increased to 288 million in 2024Q3 from 273 million in 2024Q2 representing a change of 5.52%. This indicates an increase in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 118 million in 2024Q3 from 110 million in 2024Q2 representing a change of 7.25%. This indicates an increase in available liquid assets.

  Total Current Assets: Total Current Assets increased to 787 million in 2024Q3 from 759 million in 2024Q2 representing a change of 3.72%. This indicates a better liquidity position.

  Total Debt: Total Debt decreased to 578 million in 2024Q3 from 583 million in 2024Q2 representing a change of -0.88%. This indicates a reduction in overall debt burden.

• 📉 Negative Indicators

  Total Liabilities: Total Liabilities increased to 1,099 million in 2024Q3 from 1,080 million in 2024Q2 representing a change of 1.77%. This indicates an increase in overall liabilities.

  Total Current Liabilities: Total Current Liabilities increased to 500 million in 2024Q3 from 476 million in 2024Q2 representing a change of 4.84%. This indicates a higher short-term debt burden.

  Retained Earnings: Retained Earnings decreased to 0 million in 2024Q3 from 984 million in 2024Q2 representing a change of -100.0%. This indicates an accumulated losses.

Cashflow Statements ⓘ

• Annual Cashflow Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0001005757
net change in cash	35899000	-2884000	1,344.76
operating cash flow	131895999	63597000	107.39
free cash flow	103918999	26606000	290.58
capital expenditure	-27977000	-36991000	24.37
depreciation and amortization	69289000	76951000	-9.96
deferred income tax	-23560000	-27627000	14.72
stock based compensation	28990000	27243000	6.41
accounts payables	12541000	-36971000	133.92
inventory	0	0	NaN
acquisitions net	0	0	NaN
investments in property plant and equipment	-27977000	-36991000	24.37
net cash used for investing activites	-27906000	-9038000	-208.76
debt repayment	-127961000	-264801000	51.68
common stock issued	3284000	2969000	10.61
common stock repurchased	-127065000	-96720000	-31.37
dividends paid	-33930000	-33475000	-1.36
net cash used provided by financing activities	-31305000	-51685000	39.43
cash at end of period	186264000	389018000	-52.12
accounts receivables	-22401000	-51005000	56.08
cash at beginning of period	150365000	391902000	-61.63

Overall Score of Annual Cashflow Statement

0.44 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to 36 million in 2023 from -3 million in 2022 representing a change of 1344.76%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Operating Cash Flow: Operating Cash Flow increased to 132 million in 2023 from 64 million in 2022 representing a change of 107.39%. This indicates that the company generated more cash from its core business operations.

  Free Cash Flow: Free Cash Flow increased to 104 million in 2023 from 27 million in 2022 representing a change of 290.58%. This indicates an increase in cash generated after accounting for capital expenditures.

  Accounts Payables: The absolute value of Accounts Payables decreased to 13 million in 2023 from 37 million in 2022 representing a change of 133.92%. This indicates that the company has reduced its outstanding obligations to its suppliers.

• 📉 Negative Indicators

  Capital Expenditure: Capital Expenditure increased to -28 million in 2023 from -37 million in 2022 representing a change of 24.37%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.

  Deferred Income Tax: Deferred Income Tax increased to -24 million in 2023 from -28 million in 2022 representing a change of 14.72%. This indicates that the company's tax liability for future periods has increased.

  Stock-Based Compensation: Stock-Based Compensation increased to 29 million in 2023 from 27 million in 2022 representing a change of 6.41%. This indicates increased expenses, which is generally considered a negative sign from a financial perspective.

  Accounts Receivables: Accounts Receivables increased to -22 in 2023 from -51 million in 2022 representing a change of 56.08%. This suggests that the company is less capable of collecting payments from its customers.

  Dividends Paid: Dividends Paid decreased to -34 million in 2023 from -33 million in 2022 representing a change of -1.36%. This indicates a weaker financial position, less confidence in future prospects, and a reluctance to return value to shareholders.

• Quarterly Cashflow Statement

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0001005757
operating cash flow	39459000	43105000	-8.46
free cash flow	32004000	38806000	-17.53
capital expenditure	-7455000	-4299000	-73.41
depreciation and amortization	-17558000	17337000	-201.27
deferred income tax	-2500000	-5548000	54.94
stock based compensation	8652000	8635000	0.20
accounts receivables	-8765000	11851000	-173.96
accounts payables	3938000	6985000	-43.62
inventory	0	0	NaN
acquisitions net	0	17293000	-100.00
investments in property plant and equipment	-7455000	-4299000	-73.41
net cash used for investing activites	-7455000	12994000	-157.37
debt repayment	-2028000	-2344000	13.48
common stock issued	798000	752000	6.12
common stock repurchased	-14496000	-9970000	-45.40
dividends paid	-8510000	-8625000	1.33
net cash used provided by financing activities	-18708000	-26678000	29.87
net change in cash	250551000	-10375000	2,514.95
cash at end of period	360986000	110435000	226.88
cash at beginning of period	110435000	120810000	-8.59

Overall Score of Quarterly Cashflow Statement

0.56 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to 251 million in 2024Q3 from -10 million in 2024Q2 representing a change of 2514.95%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Capital Expenditure: Capital Expenditure decreased to -7 million in 2024Q3 from -4 million in 2024Q2 representing a change of -73.41%. This indicates a possible improved efficiency or a shift in the company's strategic priorities.

  Accounts Payables: The absolute value of Accounts Payables decreased to 4 million in 2024Q3 from 7 million in 2024Q2 representing a change of -43.62%. This indicates that the company has reduced its outstanding obligations to its suppliers.

  Accounts Receivables: Accounts Receivables decreased to -9 million in 2024Q3 from 12 million in 2024Q2 representing a change of -173.96%. This suggests that the company has been able to collect payments from its customers more efficiently and timely.

  Dividends Paid: Dividends Paid increased to -9 million in 2024Q3 from -9 million in 2024Q2 representing a change of 1.33%. This indicates a stronger financial position, more confidence in future prospects, and a better commitment to returning value to shareholders.

• 📉 Negative Indicators

  Operating Cash Flow: Operating Cash Flow decreased to 39 million in 2024Q3 from 43 million in 2024Q2 representing a change of -8.46%. This indicates that the company generated less cash from its core business operations.

  Free Cash Flow: Free Cash Flow decreased to 32 million in 2024Q3 from 39 million in 2024Q2 representing a change of -17.53%. This indicates a decrease in cash generated after accounting for capital expenditures.

  Deferred Income Tax: Deferred Income Tax increased to -2 million in 2024Q3 from -6 million in 2024Q2 representing a change of 54.94%. This indicates that the company's tax liability for future periods has increased.

  Stock-Based Compensation: Stock-Based Compensation increased to 9 million in 2024Q3 from 9 million in 2024Q2 representing a change of 0.2%. This indicates increased expenses, which is generally considered a negative sign from a financial perspective.

Earnings Transcripts ⓘ

We save you time by utilizing Generative AI to summarize earnings transcripts. Our summaries provide a clear insight into the company's current performance, future outlook, and overall sentiment expressed during the call. Click on below links to explore more.

Note: The years mentioned below are fiscal years in accounting.

Q3 2024 Earnings call transcript
Q2 2024 Earnings call transcript
Q1 2024 Earnings call transcript
Q4 2023 Earnings call transcript
Q3 2023 Earnings call transcript
Q2 2023 Earnings call transcript
Q1 2023 Earnings call transcript
Q4 2022 Earnings call transcript

Earnings Per Share (EPS) ⓘ

Analyst Stock Recommendations ⓘ

Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.

Financial Ratios ⓘ

• Annual Financial Ratios

	2023-12-31	2022-12-31	Y/Y change %
FY
calendar year	2023	2022	NaN
revenue per share	39.06	35.12	11.20
net income per share	2.21	1.42	55.83
operating cash flow per share	4.41	2.05	114.94
free cash flow per share	3.47	0.86	304.81
cash per share	12.44	4.85	156.65
book value per share	9.13	11.45	-20.26
tangible book value per share	-2.85	-0.55	-421.15
shareholders equity per share	9.13	11.45	-20.26
interest debt per share	19.69	16.23	21.34
market cap	1593000980	1774801600	-10.24
enterprise value	1999539980	2111624600	-5.31
pe ratio	24.05	40.28	-40.30
price to sales ratio	1.36	1.63	-16.35
pocfratio	12.08	27.91	-56.72
pfcf ratio	15.33	66.71	-77.02
pb ratio	5.83	5.0	16.66
ptb ratio	5.83	5.0	16.66
ev to sales	1.71	1.94	-11.75
enterprise value over ebitda	9.37	10.16	-7.71
ev to operating cash flow	15.16	33.2	-54.34
ev to free cash flow	19.24	79.37	-75.76
earnings yield	0.04	0.02	67.51
free cash flow yield	0.07	0.01	335.16
debt to equity	2.04	1.37	48.98
debt to assets	0.39	0.36	7.12
net debt to ebitda	1.91	1.62	17.63
current ratio	1.54	1.45	5.82
interest coverage	4.62	7.97	-42.03
income quality	1.99	1.44	37.94
dividend yield	0.02	0.02	12.93
payout ratio	0.51	0.76	-32.59
sales general and administrative to revenue	0	0	NaN
research and ddevelopement to revenue	0.12	0.13	-3.23
intangibles to total assets	0.25	0.28	-9.94
capex to operating cash flow	0.21	0.58	-63.53
capex to revenue	0.02	0.03	-29.51
capex to depreciation	0.4	0.48	-16.00
stock based compensation to revenue	0.02	0.02	-0.82
graham number	21.32	19.13	11.47
roic	0.12	0.11	10.24
return on tangible assets	0.06	0.05	35.38
graham net net	-17.83	-19.23	7.28
working capital	301390000	238746000	26.24
tangible asset value	-85373000	-16978000	-402.84
net current asset value	-307494000	-227349000	-35.25
invested capital	759917000	732447000	3.75
average receivables	339738500	307411000	10.52
average payables	47063000	41558500	13.25
average inventory	0	0.5	-100.00
days sales outstanding	109.63	109.96	-0.30
days payables outstanding	26.38	30.82	-14.39
days of inventory on hand	0	0	NaN
receivables turnover	3.33	3.32	0.30
payables turnover	13.83	11.84	16.80
inventory turnover	0	0	NaN
roe	0.24	0.12	95.42
capex per share	0.93	1.19	-21.61

• Positive

  ROE: Return on Equity (ROE) increased to 0.24 on 2023-12-31 from 0.12 on 2022-12-31, representing a change of 95.42%. Suggesting the company has been generating high returns for its shareholders.

  Current Ratio: Current Ratio increased to 1.54 on 2023-12-31 from 1.45 on 2022-12-31, representing a change of 5.82%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. Also, it's above 1, indicating the ability to cover short-term obligations.

• Negative

  PE Ratio: Price-to-Earnings (P/E) Ratio decreased to 24.05 on 2023-12-31 from 40.28 on 2022-12-31, representing a change of -40.30%. Indicating a decrease in the relative valuation of the company's stock.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio increased to 2.04 on 2023-12-31 from 1.37 on 2022-12-31, representing a change of 48.98%. The debt-to-equity ratio has been increasing, indicating that the company has been relying more on debt financing. A ratio of 2.0 or higher is usually considered risky.

• Quarterly Financial Ratios

	2024-09-30 Q3	2024-06-30 Q2	Q/Q change %
CSGS
calendar year	2024	2024	NaN
revenue per share	10.41	10.17	2.32
net income per share	0.67	0.48	38.92
operating cash flow per share	1.39	1.51	-7.86
free cash flow per share	1.13	1.36	-16.99
cash per share	4.18	3.87	7.95
book value per share	10.17	9.58	6.20
tangible book value per share	-1.24	-5.93	79.15
shareholders equity per share	10.17	9.58	6.20
interest debt per share	20.1	19.72	1.92
market cap	1379811300	1155827540	19.38
enterprise value	1839282300	1628437540	12.95
pe ratio	18.07	20.89	-13.51
price to sales ratio	4.68	3.98	17.43
pocfratio	34.97	26.81	30.41
pfcf ratio	43.11	29.78	44.75
pb ratio	4.78	4.23	13.14
ptb ratio	4.78	4.23	13.14
ev to sales	6.23	5.61	11.10
enterprise value over ebitda	57.8	32.0	80.63
ev to operating cash flow	46.61	37.78	23.38
ev to free cash flow	57.47	41.96	36.95
earnings yield	0.01	0.01	15.62
free cash flow yield	0.02	0.03	-30.92
debt to equity	2.0	2.03	-1.37
debt to assets	0.42	0.41	1.51
net debt to ebitda	14.44	9.29	55.48
current ratio	1.58	1.59	-1.07
interest coverage	-4.09	4.36	-193.86
income quality	2.07	3.12	-33.68
dividend yield	0.01	0.01	-17.35
payout ratio	0.45	0.62	-28.52
sales general and administrative to revenue	0	0	NaN
research and ddevelopement to revenue	0.14	0.13	6.70
intangibles to total assets	0.23	0.33	-28.70
capex to operating cash flow	0.19	0.1	89.44
capex to revenue	0.03	0.01	70.58
capex to depreciation	-0.42	0.25	-271.23
stock based compensation to revenue	0.03	0.03	-1.44
graham number	12.41	10.22	21.47
roic	0.04	0.03	57.06
return on tangible assets	0.02	0.02	18.16
graham net net	-34.57	-24.48	-41.21
working capital	287731000	282597000	1.82
tangible asset value	-35038000	-169154000	79.29
net current asset value	-311795000	-320918000	2.84
invested capital	695375000	812847000	-14.45
average receivables	180406000	361441000	-50.09
average payables	52384500	48315000	8.42
average inventory	0	0.5	-100.00
days sales outstanding	0	111.85	-100.00
days payables outstanding	31.25	30.07	3.94
days of inventory on hand	0	0	NaN
receivables turnover	0	0.8	-100.00
payables turnover	2.88	2.99	-3.79
inventory turnover	0	0	NaN
roe	0.07	0.05	30.81
capex per share	0.26	0.15	74.54

• ROE:

• Negative

  PE Ratio: Price-to-Earnings (P/E) Ratio decreased to 18.07 on 2024-09-30 Q3 from 20.89 on 2024-06-30 Q2, representing a change of -13.51%. Indicating a decrease in the relative valuation of the company's stock.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 2.00 on 2024-09-30 Q3 from 2.03 on 2024-06-30 Q2, representing a change of -1.37%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. However, a ratio of 2.0 or higher is usually considered risky.

• Neutral

  Current Ratio: Current Ratio decreased to 1.58 on 2024-09-30 Q3 from 1.59 on 2024-06-30 Q2, representing a change of -1.07%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. However, it is still above 1, indicating the ability to cover short-term obligations.

Growth Rates ⓘ

• Annual Growth

• Quarterly Growth

Intrinsic Value (Discounted Cash Flow) ⓘ

Positive Sentiment: Discounted Cash Flow value is 70.24 which is higher than current price 55.58, indicates the company may be undervalued.